Everolimus. Information for patients Sheffield Kidney Institute (Renal Unit)

Similar documents
Outpatient care for patients with neutropenia. Information for patients Weston Park Hospital

Mycophenolate treatment for respiratory conditions. Information for patients Respiratory Medicine - Asthma

Looking after yourself with early chronic kidney disease. Information for patients Sheffield Kidney Institute (Renal Unit)

Use of steroids in neurological conditions. Information for patients Pharmacy

Renal psychology service. Information for patients Department of Psychological Services

Azathioprine treatment for respiratory conditions. Information for patients Respiratory Medicine - Asthma

Intravenous anti-cancer treatment

Acute kidney injury. Information for patients Sheffield Teaching Hospitals

Treating inflammatory bowel disease

Leflunomide Treatment Rheumatology Patient Information Leaflet

Having a kidney biopsy. Information for patients Sheffield Kidney Institute (Renal Unit)

Oral anti-cancer treatment

Bevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients

Having a kidney transplant: Going home after the operation. Information for patients Sheffield Kidney Institute (Renal Unit)

About your tunnelled dialysis catheter. Information for patients Sheffield Kidney Institute (Renal Unit)

About your fistula for dialysis. Information for patients Sheffield Kidney Institute (Renal Unit)

Dornase alfa (Pulmozyme ) for cystic fibrosis. Information for patients Pharmacy

Traztuzumab (Herceptin)

Bladder neck bulking injection. Information for patients Gynaecology

Pain relief after caesarean section. Information for patients Royal Hallamshire Hospital, Jessop Wing

Lidocaine adult mouthwash 2mg in 1ml. Information for patients Pharmacy

Rivaroxaban to prevent blood clots for patients who have a lower limb plaster cast. Information for patients Pharmacy

Aortic valve repair surgery

Plasma exchange. Information for patients Sheffield Kidney Institute (Renal Unit)

Preventing blood clots while you are in hospital and after you leave. Information for patients Pharmacy

Botox for chronic migraine. Information for patients Neurology

About your graft for dialysis. Information for patients Sheffield Kidney Institute (Renal Unit)

Thrombolysis in stroke patients. Information for patients Neurology

Lidocaine Hydrochloride BP 2% w/v in Lutrol F127 24% w/v Sterile Gel. Information for patients Pharmacy

Your visit to the Breast Clinic. Information for patients Breast Services

What is a lumbar puncture? Information for patients Outpatient Parenteral Antibiotic Therapy Service

Haematuria Clinic. Information for patients Urology PROUD TO MAKE A DIFFERENCE SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST

What is a lumbar puncture? Information for patients Neurology

Your visit to the Nuclear Medicine Department. Information for patients Nuclear Medicine

The Colorectal (bowel) Family History Clinic. Information for patients Endoscopy

Arteriovenous malformation (AVM)

We will review the need for continuing treatment with you after 3 months and again after one year.

Removal of external fixator. Information for patients Sheffield Teaching Hospitals

Mallet finger. Information for patients The Sheffield Hand Centre

If your IBD has not been well controlled, or is flaring up quite often, methotrexate may be added to your treatment.

Methotrexate for inflammatory bowel disease: what you need to know

Suprapubic catheter insertion in the radiology department. Information for patients Urology

Liver biopsy. Information for patients Hepatobiliary

Consent for radical radiotherapy to the brain. Information for patients Weston Park Hospital

Pancreas transplants. What you need to know. Information for patients Sheffield Kidney Institute (Renal Unit)

Laparoscopic (keyhole) colorectal (bowel) resection

Transitioning from children's to adult audiology services. Information for patients Regional Department of Neurotology

Weekly methotrexate tablets

Capecitabine (Xeloda) tablets

Abdominal aortic aneurysm. Information for patients Sheffield Vascular Institute

Hospital No. Weston Park Hospital contact number

CT myelogram. Information for patients Radiology

1. and it is more than 12 hours until your next dose, take the missed dose and continue with your normal schedule

Alcohol related ataxia. Information for patients Neurology

Contents. TSC and kidneys. P3 Introduction P4 Monitoring P5 Renal (kidney) AMLs P7 Renal (kidney) cysts P8 Information and support

About barium meals and swallows. Information for patients Radiology

Herpes What is it? How is it transmitted? How is it treated?

Haematology Mycophenolate Mofetil Information for patients

Etoposide Cisplatin / Etoposide, Methotrexate, Actinomycin

Ectropion repair. To improve eye lid position. Information for patients Ophthalmology (Ocular Plastics) Large Print

Methotrexate in Inflammatory Bowel Disease. An information guide

Injection sclerotherapy. Information for patients Sheffield Vascular Institute

Intermittent self catheterisation (ISC) Information for patients Gynaecology

National Neuromyelitis Optica Service

Spinal Cord Stimulation (SCS) and Dorsal Root Ganglion Stimulation (DRG) Information for patients

Removal of external fixator

Video urodynamics in spinal injuries. Information for patients Spinal Injuries

Nebulised tobramycin for cystic fibrosis. Information for patients Pharmacy

Understanding Methotrexate

Infliximab Drug information. Infliximab can treat rheumatoid arthritis and psoriatic arthritis.

Trans urethral resection of prostate (TURP)

Intra-gastric balloon procedure. Information for patients Sheffield Centre for Weight Loss Surgery

Cystoscopy. Information for patients Spinal Injuries

Caudal epidural. Information for patients Pain Management Service

Thoracic outlet syndrome and cervical or first rib removal. Information for patients Sheffield Vascular Institute

Sorafenib (Nexavar ) For thyroid carcinoma

Autogenic drainage. A guide for patients. Information for patients Therapy Services - Surgical

If your IBD has not been well controlled, or is flaring up quite often, tacrolimus may be added to your treatment.

Atropine eye drops for treatment of a lazy eye

Tacrolimus. Information for patients about using the drug Tacrolimus.

Transjugular intrahepatic portosystemic shunt (TIPS) Information for patients Sheffield Vascular Institute

Information on Azathioprine for Inflammatory Bowel Disease

Total elbow replacement. Information for patients Orthopaedics - Upper Limb

Herbal medicines and supplements for cancer patients

Cyclophosphamide Treatment (To be used in conjunction with the Shared Care Blood Test Monitoring Card)

Endovascular repair for abdominal aortic aneurysm (EVAR) Information for patients Sheffield Vascular Institute

Mycophenolate (Mofetil)

BSL communication support during pregnancy and birth

Pentostatin (Nipent )

Vascular malformation embolisation. Information for patients Sheffield Vascular Institute

Arthroscopic capsular release. Information for patients Orthopaedics - Upper Limb

Carpal tunnel syndrome in pregnancy. Information for patients MSK Outpatients - Women's Health (Therapy)

Volar plate avulsion injury. Information for patients The Sheffield Hand Centre

Methotrexate Treatment Rheumatology Patient Information Leaflet

Drug information. Tofacitinib TOFACITINIB. is used to treat rheumatoid arthritis and psoriatic arthritis. Helpline

Carotid Endarterectomy

Physiotherapy and cystic fibrosis

Indwelling urinary catheters for managing your bladder. Information for patients Northern General Hospital

Are you aged up to 25 years and starting university for the first time?

Vitamin and mineral supplements after weight loss surgery. Information for patients Sheffield Dietetics

Transcription:

Everolimus Information for patients Sheffield Kidney Institute (Renal Unit)

Everolimus for angiomyolipomas in tuberous sclerosis What is tuberous sclerosis? Tuberous sclerosis is a rare condition caused by a faulty gene. In around three in every four cases, the genetic fault happens for no apparent reason in people without any other affected family members. In the remaining one in four cases, the fault is passed on to a child by their parents. Only one parent needs to carry the faulty gene to pass it on. A parent who has one of the faulty genes has a one in two chance of passing it on to each child they have. The parent carrying the faulty gene will also have tuberous sclerosis, although sometimes it may be so mild that they don't realise it. Tuberous sclerosis, causes mainly non-cancerous (benign) tumours (growths) to develop in different parts of the body. The tumours most often affect the brain, skin, kidneys, heart, eyes and lungs. Tuberous sclerosis is present from birth, although it may not cause obvious problems straight away. It's estimated that around 1 in every 6,000 babies are born with the condition. What are angiomyolipomas? Angiomyolipomas are benign (non-cancerous) growths that occur in the kidney in up to 80% of patients with tuberous sclerosis. The growths mainly cause problems through bleeding around the kidneys. The bigger the growths, the more likely they are to bleed. page 2 of 8

Stopping the bleeding sometimes requires a procedure or an operation to block the blood flow to the affected area. As angiomyolipomas get bigger, they can reduce kidney function by pressing on the surrounding normal kidney tissue. How do I know if I have angiomyolipomas? You will have had CT or MRI scans and these will have shown the growths in the kidneys. You may have also had other tests and investigations to look for signs of the condition. You may also be asked about your family history of health problems. From these, your doctor will have diagnosed your tuberous sclerosis. What is the treatment for tuberous sclerosis? Tuberous sclerosis is a lifelong condition and there is no cure. You will need long-term care and support from a number of different healthcare professionals. Regular testing is important for people with tuberous sclerosis. This is so that the function of the parts of the body often affected by the condition, in your case the kidneys, can be regularly monitored and assessed. Everolimus may be used to stop tumours becoming too large, as large tumours can cause dangerous bleeding. page 3 of 8

What is everolimus (Votubia )? Everolimus is a tablet that can reduce the size of angiomyolipomas (growths). If you have angiomyolipomas that are at least 3cm in size your doctor will recommend you have this treatment. The aim of this treatment is to reduce the size of the growths and so reduce the risk of bleeding. You will need scans at regular intervals to monitor size of the angiomyolipomas and to check for any new growths. How do I take everolimus? Everolimus is a tablet that is taken once every day. It is important that you take the tablet at about the same time each day. How long do I need to take everolimus for? You need to take everolimus long term to stop angiomyolipomas growing. After you have had 6 months of treatment your kidneys will be re-scanned to see whether the angiomyolipomas have grown. If the scan shows that the angiomyolipomas have grown, or you have still had bleeding whilst taking everolimus, the treatment will be stopped as it is not working for you. page 4 of 8

What if I miss a dose? If you miss a dose you should not take extra tablets to make up for this. Just take the next dose as usual. What are the side effects of everolimus? The most common side effects that can occur with everolimus are: Sore mouth (stomatitis) Acne-like rash Sore throat and runny nose Headache Diarrhoea Cough Slower wound healing; if you need an operation then everolimus should be stopped Other possible side effects are monitored with blood and urine tests: Increased blood cholesterol or glucose levels Reduced white blood cells or platelets Abnormal liver function blood tests Increased protein in the urine Everolimus suppresses (dampens) the immune system so it doesn t work as well. This may mean you get more frequent or severe infections. If you become unwell with a fever whilst taking everolimus you should contact us straight away. We explain how to do this at the end of the leaflet. page 5 of 8

Does everolimus interact with other tablets? Some other tablets interfere with everolimus, increasing or decreasing its effects. If any healthcare professional wants to start you on any new medication, you must tell them that you are also taking everolimus. If they want advice they can contact the renal unit for help. Can I take everolimus if I am pregnant or breastfeeding? Everolimus must not be taken while you are pregnant or breastfeeding. If it is possible you could become pregnant, you must use effective contraception (birth control) while you take everolimus and for 8 weeks after stopping treatment. Do I need to attend regular hospital appointments? Yes. It is important that your blood and urine are checked for any possible side effects. Your kidney doctor will tell you how often. Can I have vaccines? You should not have live vaccines (such as typhoid, polio, rubella, BCG, chicken pox, shingles) whilst taking everolimus. It is safe to have the pneumococcal and flu vaccines. If your GP or practice nurse is not sure if you can have a vaccine, they can contact the renal unit for advice. page 6 of 8

Where can I find out more information? More information on tuberous sclerosis is available on the following websites: - www.tuberous-sclerosis.org/ - www.nhs.uk/conditions/tuberous-sclerosis/pages/introduction.aspx Use the space below to write down any questions you have for the doctors when you come to clinic. page 7 of 8

If you have any urgent questions or concerns please contact: Renal Assessment Unit 0114 271 5320 Monday to Thursday: 8.30am - 4.00pm Friday: 8.30am - 3.30pm In an emergency outside of these hours: Renal F Floor 0114 226 6391 or 0114 271 5886 For general information call: Janet McCormick, Renal Nurse Specialist, Sorby Renal Outpatients 0114 271 4410 Monday to Thursday: 8.30am - 4.30pm Produced with support from Sheffield Hospitals Charity Working together we can help local patients feel even better To donate visit www.sheffieldhospitalscharity.org.uk Registered Charity No 1169762 Alternative formats can be available on request. Please email: alternativeformats@sth.nhs.uk Sheffield Teaching Hospitals NHS Foundation Trust 2017 Re-use of all or any part of this document is governed by copyright and the Re-use of Public Sector Information Regulations 2005 SI 2005 No.1515. Information on re-use can be obtained from the Information Governance Department, Sheffield Teaching Hospitals. Email infogov@sth.nhs.uk PD9451-PIL4009 v1 Issue Date: December 2017. Review Date: December 2019